重新聚焦泛性肌痛性肌痛症:患者负担,疾病概况,以及不断变化的疗法作用
Francesco Saccà1, Emmanuelle Salort-Campana2, Saiju Jacob3
1Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy.
European journal of neurology
|December 20, 2023
概括
一般化肌痛性肌痛症 (gMG) 管理正在随着新疗法的发展而发展. 标准化的评估和有针对性的治疗对于改善gMG患者的治疗结果和生活质量至关重要.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 泛性肌痛性肌痛症 (gMG) 存在复杂的管理挑战,原因是无法预测的疾病进程和可变的治疗反应.
- 新的药理疗法需要对GMG分类,评估和管理策略进行重新评估.
研究的目的:
- 审查关于一般化肌痛性肌痛症 (gMG) 管理的当前文献.
- 确定需要改善gMG患者分类,评估和治疗策略的需求.
- 探索新型疗法在优化GMG护理中的作用.
主要方法:
- 对PubMed的出版物和选定的大会进行叙事审查.
- 从2000年1月到2022年9月进行的文献搜索.
主要成果:
- 需要新的共识定义来实现一致的患者表征,并指导gMG中的向治疗选择.
- 标准化,频繁的患者评估对于了解疾病负担,对日常生活的影响和生活质量 (QoL) 是必不可少的.
- 新型免疫调节方法和个性化管理的新算法是精确的gMG治疗的关键.
结论:
- 尽管采用标准治疗方法,但gMG显著影响身体,精神和社会福祉,降低了QoL.
- 新型向治疗和生物标志物为优化GMG管理提供了潜力.
- 这些进展可能使更多的患者能够达到最小的表现状态,并减少疾病负担.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
01:15Myasthenia Gravis: Diagnostic Tests
872
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
872
01:28Disorders of the Skeletal Muscle
958
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
958
01:28Drug Therapy
45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
45
01:29Inflammatory Bowel Disease IV: Pharmacological Management
128
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
128
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
675
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
675